Evome Medical Technologies Inc. (LNDZF)
| Previous Close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0111 x 0 |
| Ask | 0.1500 x 0 |
| Day's Range | 0.1000 - 0.1000 |
| 52 Week Range | 0.0400 - 0.3000 |
| Volume | |
| Avg. Volume | 814 |
| Market Cap | 11.567M |
| Beta (5Y Monthly) | 1.98 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1700 |
| Earnings Date | May 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 24, 2017 |
| 1y Target Est | N/A |
- GlobeNewswire
Evome Medical Technologies Retains irlabs for Investor Relations Services
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs Inc. ("irlabs") to provide the Company with investor relations and communications services. “We look forward to this partnership with irlabs as we work to raise our profile in the investment community,” said Mike Seckler, CEO. “In tandem with their expert team, we’re confident we can amplify our stor
- GlobeNewswire
Evome Medical Technologies Announces Securities Issuances
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the “TSXV”) to complete a shares for services transaction with Beacon Securities Limited (“Beacon”) pursuant to which the Company will issue Beacon 504,286 common shares of the Company at a deemed price of $0.1983 per share in satisfaction of $100,000 of advisory services. The shares issuable will be
- GlobeNewswire
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April and May 2024, the first two months of the second quarter. Mike Seckler, Chief Executive Officer of the Company, will also hold a call to update shareholders on the first quarter financials, second quarter progress and future plans of the Company. Revenue Growth Update for Q2 2024 For April and May 2024,
